These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7214247)
21. [A case of metrizamide encephalopathy--a review of papers in respect of prevention and therapy against major side effects of metrizamide]. Takahashi T; Nakamura K; Tajima M No Shinkei Geka; 1983 Jul; 11(7):771-9. PubMed ID: 6621798 [No Abstract] [Full Text] [Related]
22. Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography. Yu YL; du Boulay GH; Paul E Neuroradiology; 1986; 28(4):339-43. PubMed ID: 3762912 [TBL] [Abstract][Full Text] [Related]
27. Cognitive and affective changes after myelography: a comparison of metrizamide and iohexol. Ratcliff G; Sandler S; Latchaw R AJR Am J Roentgenol; 1986 Oct; 147(4):777-81. PubMed ID: 3489380 [TBL] [Abstract][Full Text] [Related]
31. Nonconvulsive status epilepticus following metrizamide myelography. Pritchard PB; O'Neal DB Ann Neurol; 1984 Aug; 16(2):252-4. PubMed ID: 6433781 [TBL] [Abstract][Full Text] [Related]
32. Comparison of iohexol with metrizamide in myelography. Sortland O; Nestvold K; Kloster R; Aandahl MH Radiology; 1984 Apr; 151(1):121-2. PubMed ID: 6701301 [TBL] [Abstract][Full Text] [Related]
33. Prevention of adverse reactions to Amipaque in cervical myelography. Report of a homogeneous series of 380 patients. Legré J; Lavieille J; Debaène A; Tapias PL; Vaillant J J Neuroradiol; 1981; 8(4):353-61. PubMed ID: 6799618 [No Abstract] [Full Text] [Related]
34. Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study. Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD Invest Radiol; 1985; 20(1 Suppl):S22-30. PubMed ID: 3882614 [TBL] [Abstract][Full Text] [Related]
35. Absence status epilepticus with computed tomographic brain changes following metrizamide myelography. Obeid T; Yaqub B; Panayiotopoulos C; al-Jasser S; Shabaan A; Hawass NE Ann Neurol; 1988 Oct; 24(4):582-4. PubMed ID: 3239959 [TBL] [Abstract][Full Text] [Related]
36. Transient encephalopathy and asterixis following metrizamide myelography. Case report. Chehrazi B; Virapongse C J Neurosurg; 1981 Nov; 55(5):826-9. PubMed ID: 7310506 [TBL] [Abstract][Full Text] [Related]
37. Lumbar myelography with amipaque. Irstam L Spine (Phila Pa 1976); 1978 Mar; 3(1):70-82. PubMed ID: 205957 [TBL] [Abstract][Full Text] [Related]
38. Cortical blindness after metrizamide myelography. Report of a case and proposed pathophysiologic mechanism. Smirniotopoulos JG; Murphy FM; Schellinger D; Kurtzke JF; Borts FT Arch Neurol; 1984 Feb; 41(2):224-6. PubMed ID: 6691831 [TBL] [Abstract][Full Text] [Related]
39. The effect of dehydration on the side effects of metrizamide myelography. Eldevik OP; Nakken KO; Haughton VM Radiology; 1978 Dec; 129(3):715-6. PubMed ID: 152937 [TBL] [Abstract][Full Text] [Related]
40. [Clinical and electroencephalographic signs of side effects in patients after myelography using "amipaque"]. Dobrzyńska L; Mierzejewska E; Sokół A Neurol Neurochir Pol; 1985; 19(3):221-6. PubMed ID: 4047300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]